Welcome to our dedicated page for Cambridge Acquisition news (Ticker: CAQUU), a resource for investors and traders seeking the latest updates and insights on Cambridge Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cambridge Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cambridge Acquisition's position in the market.
Cambridge Acquisition Corp (NASDAQ:CAQUU) closed its initial public offering of 23,000,000 units at $10.00 per unit, including a full 3,000,000-unit over-allotment, generating $230,000,000 in gross proceeds. Units began trading on Nasdaq Global Market under CAQUU on February 6, 2026.
Each unit comprises one Class A ordinary share and one-third of one redeemable warrant; whole warrants will trade as CAQUW and exercise price is $11.50. A registration statement was declared effective by the SEC on January 30, 2026, and BTIG acted as sole book-running manager.
Cambridge Acquisition Corp. (NASDAQ: CAQUU) priced a $200 million initial public offering of 20,000,000 units at $10.00 per unit, each unit containing one Class A ordinary share and one-third of a redeemable warrant. Whole warrants exercise at $11.50 per share and will trade as CAQUW once separated.
The units are expected to begin trading on the Nasdaq Global Market on February 6, 2026, with closing targeted for February 9, 2026, subject to customary closing conditions. BTIG is sole book-running manager and a 45-day option covers up to 3,000,000 additional units for over-allotments.
FAQ
What is the current stock price of Cambridge Acquisition (CAQUU)?
